CR20230458A - Nuevos moduladores alostéricos negativos ciclopenta[c]pirrol de NR2B - Google Patents

Nuevos moduladores alostéricos negativos ciclopenta[c]pirrol de NR2B

Info

Publication number
CR20230458A
CR20230458A CR20230458A CR20230458A CR20230458A CR 20230458 A CR20230458 A CR 20230458A CR 20230458 A CR20230458 A CR 20230458A CR 20230458 A CR20230458 A CR 20230458A CR 20230458 A CR20230458 A CR 20230458A
Authority
CR
Costa Rica
Prior art keywords
cyclopental
nr2b
pyrrol
novel
allosteric modulators
Prior art date
Application number
CR20230458A
Other languages
English (en)
Inventor
Kate Yaping Wang
Mark Patrick Healy
Keith Jendza
Yue Pan
Fan Yang
Kevin Matthew Gardinier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CR20230458A publication Critical patent/CR20230458A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente divulgación proporciona un compuesto de la fórmula (I), o una sal farmacéuticamente aceptable del mismo;(I) un método para fabricar los compuestos de la divulgación y sus usos terapéuticos. La presente divulgación proporciona además una combinación de agentes farmacológicamente activos y una composición farmacéutica.
CR20230458A 2021-03-26 2022-03-24 Nuevos moduladores alostéricos negativos ciclopenta[c]pirrol de NR2B CR20230458A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163166516P 2021-03-26 2021-03-26
PCT/US2022/021624 WO2022204336A1 (en) 2021-03-26 2022-03-24 Novel cyclopental[c]pyrrol negative allosteric modulators of nr2b

Publications (1)

Publication Number Publication Date
CR20230458A true CR20230458A (es) 2023-10-27

Family

ID=83396075

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20230458A CR20230458A (es) 2021-03-26 2022-03-24 Nuevos moduladores alostéricos negativos ciclopenta[c]pirrol de NR2B

Country Status (16)

Country Link
EP (1) EP4313041A1 (es)
JP (1) JP2024509325A (es)
KR (1) KR20230160906A (es)
CN (1) CN117157072A (es)
AR (1) AR125594A1 (es)
AU (1) AU2022244367A1 (es)
BR (1) BR112023018766A2 (es)
CA (1) CA3212203A1 (es)
CO (1) CO2023012711A2 (es)
CR (1) CR20230458A (es)
DO (1) DOP2023000205A (es)
EC (1) ECSP23073082A (es)
IL (1) IL305601A (es)
TW (1) TW202304885A (es)
UY (1) UY39688A (es)
WO (1) WO2022204336A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2879126A1 (en) * 2012-07-19 2014-01-23 Janssen Pharmaceutica Nv Octahydro-cyclopentapyrrolyl antagonists of ccr2
JO3579B1 (ar) * 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
CN107849009B (zh) * 2015-10-13 2021-03-02 四川海思科制药有限公司 一种八氢环戊二烯并[c]吡咯衍生物及其制备方法和在医药上的用途

Also Published As

Publication number Publication date
UY39688A (es) 2022-10-31
KR20230160906A (ko) 2023-11-24
CO2023012711A2 (es) 2023-10-19
CN117157072A (zh) 2023-12-01
EP4313041A1 (en) 2024-02-07
ECSP23073082A (es) 2023-10-31
AU2022244367A1 (en) 2023-09-07
JP2024509325A (ja) 2024-02-29
AR125594A1 (es) 2023-08-02
TW202304885A (zh) 2023-02-01
IL305601A (en) 2023-11-01
DOP2023000205A (es) 2023-11-15
WO2022204336A1 (en) 2022-09-29
CA3212203A1 (en) 2022-09-29
BR112023018766A2 (pt) 2023-10-24

Similar Documents

Publication Publication Date Title
MX2022007350A (es) Derivados de pirazolilo utiles como agentes anticancerigenos.
CR20220456A (es) Derivados de biarilo como inhibidores de la interacción proteína-proteína de yap/taz-tead
MX2011012627A (es) Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
IN2012DN02465A (es)
MY140638A (en) New heterocyclic compounds, which are active as inhibitors of beta-lactamases
MX2011012628A (es) Derivados amino-propionicos sustituidos como inhibidores de neprilisina.
MX2013005533A (es) Derivados de acido amino-bisfenil-pentanoico sustituidos como inhibidores de nep.
MX2011012199A (es) Derivados de benzoxazolona como inhibidores de la sintasa de aldosterona.
MX2007006744A (es) Derivados de hidantoina utiles como inhibidores de metaloproteinasa.
MX2023002714A (es) Compuesto, agente de activacion de aldehido deshidrogenasa 2, composicion farmaceutica y farmaco terapeutico y/o profilactico.
MX2019014321A (es) Compuestos biciclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias.
MX2022008487A (es) Degradadores de smarca2-vhl.
CA3156320A1 (en) 2-AZASPIRO[3,4] OCTANE DERIVATIVES USED AS M4 AGONISTS
CR20230458A (es) Nuevos moduladores alostéricos negativos ciclopenta[c]pirrol de NR2B
MX2023001725A (es) Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmaceuticos de los mismos.
MX2023006176A (es) Nuevos derivados de indazol acetileno.
MX2023003576A (es) Compuesto como inhibidor de la akt cinasa.
MX2022004713A (es) Derivados de tiofeno como inhibidores de xantina oxidasa y aplicacion de los mismos.
WO2024054661A3 (en) Dynamin activators
ZA202204251B (en) Compounds and compositions for the treatment of parasitic diseases
TN2011000593A1 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
WO2022104153A3 (en) Compounds and methods for treating viral infections
MX2022015986A (es) Derivados de aminopirimidinilo.
TN2011000592A1 (en) Substituted aminopropionic derivatives as neprilysin inhibitors
NO20080947L (no) Terapeutisk middel for hypertensjon